ClinicalTrials.Veeva

Menu

Investigating the Role of Ginger Tea ORAC Value in Hypertension Management

S

Superior University

Status

Active, not recruiting

Conditions

Hypertension

Treatments

Combination Product: self administred Ginger tea
Combination Product: Ginger tea

Study type

Interventional

Funder types

Other

Identifiers

NCT06762834
MSAHS/Batch-Spring23/023

Details and patient eligibility

About

The purpose of this study is to evaluate the antihypertensive effects of ginger tea. By examining its impact on blood pressure levels, this research aims to determine whether ginger tea can be an effective, natural adjunct to conventional hypertension treatments.

Full description

This investigation will provide insights into its potential role in reducing the burden of hypertension and improving cardiovascular health

Enrollment

50 patients

Sex

All

Ages

30 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adults aged 30-65 years
  • Diagnosed with stage 1 or stage 2 hypertension
  • Not currently taking antihypertensive medication
  • Willing to provide informed consent and adhere to study protocols.

Exclusion criteria

  • Pregnant or breastfeeding women
  • Participants on antioxidant supplements or other herbal teas.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

50 participants in 2 patient groups

Ginger Tea
Experimental group
Treatment:
Combination Product: Ginger tea
Self Administered Tea
Active Comparator group
Treatment:
Combination Product: self administred Ginger tea

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems